Package 13107-259-01

Brand: amphetamine sulfate

Generic: amphetamine sulfate
NDC Package

Package Facts

Identity

Package NDC 13107-259-01
Digits Only 1310725901
Product NDC 13107-259
Product ID 13107-259_992a765b-f8cb-4311-b25a-053c11a90bab
Description

100 TABLET in 1 BOTTLE (13107-259-01)

Marketing

Marketing Status
Marketed Since 2019-01-31
Brand amphetamine sulfate
Generic amphetamine sulfate
Sample Package No

Linked Drug Pages (1)

Amphetamine Sulfate ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "992a765b-f8cb-4311-b25a-053c11a90bab", "openfda": {"unii": ["6DPV8NK46S"], "rxcui": ["884655", "1600695"], "spl_set_id": ["20735c2e-6304-425f-a4e4-584f6f90d6a0"], "manufacturer_name": ["Aurolife Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (13107-259-01)", "package_ndc": "13107-259-01", "marketing_start_date": "20190131"}], "brand_name": "Amphetamine Sulfate", "product_id": "13107-259_992a765b-f8cb-4311-b25a-053c11a90bab", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "13107-259", "dea_schedule": "CII", "generic_name": "Amphetamine Sulfate", "labeler_name": "Aurolife Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amphetamine Sulfate", "active_ingredients": [{"name": "AMPHETAMINE SULFATE", "strength": "5 mg/1"}], "application_number": "ANDA211639", "marketing_category": "ANDA", "marketing_start_date": "20190131", "listing_expiration_date": "20261231"}